AQR Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Buy |
1,019,105
+273,630
| +37% | +$2.21M | 0.01% | 1050 |
|
|
2025
Q1 | $6.25M | Buy |
745,475
+408,677
| +121% | +$3.42M | 0.01% | 1041 |
|
|
2024
Q4 | $2.67M | Buy |
336,798
+33,545
| +11% | +$266K | ﹤0.01% | 1380 |
|
|
2024
Q3 | $2.52M | Sell |
303,253
-131,829
| -30% | -$1.1M | ﹤0.01% | 1383 |
|
|
2024
Q2 | $2.76M | Sell |
435,082
-321,305
| -42% | -$2.04M | ﹤0.01% | 1312 |
|
|
2024
Q1 | $4.58M | Sell |
756,387
-72,362
| -9% | -$439K | 0.01% | 1017 |
|
|
2023
Q4 | $5.03M | Sell |
828,749
-110,897
| -12% | -$673K | 0.01% | 948 |
|
|
2023
Q3 | $3.97M | Sell |
939,646
-1,216,596
| -56% | -$5.13M | 0.01% | 1018 |
|
|
2023
Q2 | $6.68M | Sell |
2,156,242
-854,660
| -28% | -$2.65M | 0.01% | 787 |
|
|
2023
Q1 | $4.19M | Buy |
3,010,902
+874,650
| +41% | +$1.22M | 0.01% | 971 |
|
|
2022
Q4 | $4.25M | Buy |
2,136,252
+1,164,091
| +120% | +$2.32M | 0.01% | 970 |
|
|
2022
Q3 | $1.96M | Buy |
972,161
+679,824
| +233% | +$1.37M | ﹤0.01% | 1209 |
|
|
2022
Q2 | $930K | Buy |
292,337
+55,339
| +23% | +$176K | ﹤0.01% | 1452 |
|
|
2022
Q1 | $988K | Buy |
+236,998
| New | +$988K | ﹤0.01% | 1540 |
|
|
2018
Q3 | – | Sell |
-41,041
| Closed | -$673K | – | 2258 |
|
|
2018
Q2 | $673K | Buy |
+41,041
| New | +$673K | ﹤0.01% | 1875 |
|